Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-16-103969
Filing Date
2016-05-20
Accepted
2016-05-20 17:11:18
Documents
6
Period of Report
2016-06-20
Effectiveness Date
2016-05-20

Document Format Files

Seq Description Document Type Size
1 DEF 14A v439550_def14a.htm DEF 14A 1544159
2 GRAPHIC line.gif GRAPHIC 43
3 GRAPHIC sig_jcook.jpg GRAPHIC 20197
4 GRAPHIC spacer.gif GRAPHIC 43
5 GRAPHIC v439550_proxycard-1.jpg GRAPHIC 1085956
6 GRAPHIC v439550_proxycard-2.jpg GRAPHIC 704665
  Complete submission text file 0001144204-16-103969.txt   4039554
Mailing Address 3579 VALLEY CENTRE DRIVE SAN DIEGO CA 92130
Business Address 3579 VALLEY CENTRE DRIVE SAN DIEGO CA 92130 804-827-2524
AmpliPhi Biosciences Corp (Filer) CIK: 0000921114 (see all company filings)

EIN.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37544 | Film No.: 161667122
SIC: 2836 Biological Products, (No Diagnostic Substances)